1
/
of
1
Sanofi Aventis
Taxotere Inf 80mg 1Vial
Taxotere Inf 80mg 1Vial
Regular price
Rs.23,100.00 PKR
Regular price
Rs.23,100.00 PKR
Sale price
Rs.23,100.00 PKR
Unit price
/
per
Couldn't load pickup availability
[tab-1][tab-title]Product Description[end-tab-title][tab-body] Generic Category: Cytotoxic
Ingredients: Docetaxel
Strength: 80mg
Pack Size: 1 Vial
Prescription Required: No [end-tab-body][end-tab-1] [tab-2][tab-title]Product Highlights[end-tab-title][tab-body] Manufacturer: Sanofi Aventi
Country of Origin: Pakistan
Pack Form: Pack of 1 Vial Infusion
Product Form: Infusion
Product Type: Medicine [end-tab-body][end-tab-2] [tab-3][tab-title]Usage and Safety Information[end-tab-title][tab-body] Key Highlights: TAXOTERE is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. TAXOTERE in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer
Storage: Store in a cool and dry place.
Habit Forming: No
Sedation: No
Child Safety: No
Route of Administration: Oral [end-tab-body][end-tab-3]
Ingredients: Docetaxel
Strength: 80mg
Pack Size: 1 Vial
Prescription Required: No [end-tab-body][end-tab-1] [tab-2][tab-title]Product Highlights[end-tab-title][tab-body] Manufacturer: Sanofi Aventi
Country of Origin: Pakistan
Pack Form: Pack of 1 Vial Infusion
Product Form: Infusion
Product Type: Medicine [end-tab-body][end-tab-2] [tab-3][tab-title]Usage and Safety Information[end-tab-title][tab-body] Key Highlights: TAXOTERE is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. TAXOTERE in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer
Storage: Store in a cool and dry place.
Habit Forming: No
Sedation: No
Child Safety: No
Route of Administration: Oral [end-tab-body][end-tab-3]
Share
